Virtual ASPC Congress focuses on diverse populations, new prevention approaches
Click Here to Manage Email Alerts
CVD prevention in Black adults, Hispanic adults and women are some of the many topics that will be discussed at this year’s virtual American Society for Preventive Cardiology Congress on CVD Prevention.
The 2-day virtual meeting will take place Saturday and Sunday. The meeting, which originally was going to be held in Louisville, Kentucky, moved to a virtual format due to the COVID-19 pandemic.
“While the focus of the American Society for Preventive Cardiology (ASPC) has always been the prevention of cardiovascular disease, this year our emphasis is placed on prevention of CVD in African Americans and Hispanics, but also women,” Peter P. Toth, MD, PhD, FAHA, FESC, FACC, director of preventive cardiology at CGH Medical Center in Sperling, Illinois; professor of clinical family and community medicine at University of Illinois College of Medicine in Peoria; professor of medicine at Michigan State University College of Osteopathic Medicine in East Lansing; and president-elect of the ASPC, told Healio. “We will explore differences among racial and ethnic groups and delineate how CVD can be different in women compared to men.”
Sessions of interest
Sessions focused in this area include the keynote lecture by Herman A. Taylor Jr., MD, MPH, professor of medicine and director of the Cardiovascular Research Institute at Morehouse School of Medicine in Atlanta, on novel insights into the CV health of Black participants from the Jackson Heart Study; a presentation on newer insights into assessing risk in Hispanic patients by Cardiology Today Editorial Board Member Ileana Pina, MD, professor in the department of medicine and the department of epidemiology and population health at Montefiore Medical Center; and a discussion on overcoming racial and ethnic disparities in clinical research and care by Hannah Valantine, MD, MRCP, chief officer for scientific workforce diversity at the NIH.
“Speakers will present the most recent data on assessing risk in minority populations, implementing solutions to health care disparities and making sure that state-of-the-art prevention strategies are available to all of those in need of them,” Toth said.
A symposium will be held Sunday on issues related to CV health of women such as menopause, coronary microvascular dysfunction and adverse pregnancy outcomes. The Nanette Wenger Lecture will be given by Cardiology Today Editorial Board Member Leslee Shaw, PhD, professor of medicine and radiology at Weill Cornell Medical College, who will discuss the potential of a sex-specific phenotype for atherosclerotic plaque. Cardiology Today Editorial Board Member Nanette Wenger, MD, MACP, MACC, FAHA, FASPC, professor of medicine (cardiology) at Emory University School of Medicine and consultant at Emory Heart and Vascular Center, will deliver the honorary fellow lecture on transforming CVD prevention for women.
Other conference highlights will include the following:
-
David Maron, MD, FACC, FAHA, FASPC, clinical professor of medicine and director of preventive cardiology and of Stanford Prevention Research Center at Stanford University School of Medicine and co-chair of the ISCHEMIA trial, will discuss lessons learned from the ISCHEMIA trial.
David Maron
-
Amit V. Khera, MD, MSc, associate director of the Precision Medicine Unit in the Center for Genomic Medicine at Massachusetts General Hospital and the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard and a Cardiology Today Next Gen Innovator, will lead a session focused on genetic testing in preventive cardiology.
Amit V. Khera
-
Cardiology Today Editorial Board Member Keith C. Ferdinand, MD, FACC, FAHA, FASPC, Gerald S. Berenson Endowed Chair in Preventive Cardiology and professor of medicine at Tulane University School of Medicine in New Orleans, will present information on polypill and other innovative approaches for risk factor management.
Keith C. Ferdinand
- A presentation by Paul Thompson, MD, emeritus chief of cardiology at Hartford Hospital in Connecticut, will discuss statin use in athletes.
- The Leaders in Medicine Lecture by Arthur Agatston, MD, CEO of the Agatston Center for Preventive Medicine in Miami Beach, will focus on the integration of imaging and advanced blood testing for CVD.
-
Paul Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital and Eugene Braunwald Professor of Medicine at Harvard Medical School, will give the Joseph Stokes Lecture on the evolution of C-reactive protein.
Paul Ridker
“Clearly, the program will be wide-ranging and comprehensive, providing a blend of cutting-edge basic science and practical medicine to be applied in the everyday practice of medicine,” Toth said.
Some sessions will only be available on an on-demand basis, Toth said, including presentations on nonalcoholic steatohepatitis and CVD, resistance to the use of apolipoprotein B in the U.S. to assess CVD risk and treat dyslipidemia, HF with preserved ejection fraction, microRNAs and atherosclerosis.
Empowering clinicians
“This conference has broad bandwidth and will empower attendees to refresh and intensify their efforts to provide optimal preventive care to patients at risk for cardiovascular disease,” Toth told Healio. “Attendees will be able to return to their clinical practices with greater understanding of and sensitivity to racial, ethnic and gender differences in their patients, be better equipped to respond to puzzling or difficult presentations and develop a stronger knowledge base of the science underlying cutting-edge research, which will most certainly wind its way into practice in the coming years.”
The Healio and Cardiology Today team will provide coverage on this Congress, including reports on the sessions described above and much more. Follow along at this link and on Twitter in the @CardiologyToday feed. For more information on the ASPC, visit www.aspconline.org.
Collapse
Click Here to Manage Email Alerts